The epidemiology of primary and metastatic brain tumors in infancy through childhood

[1]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. , 2021, Neuro-oncology.

[2]  G. Reifenberger,et al.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.

[3]  R. Malekzadeh,et al.  The histology of brain tumours for 67,331 children and 671,085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). , 2021, Neuro-oncology.

[4]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[5]  R. Siegel,et al.  An updated histology recode for the analysis of primary malignant and nonmalignant brain and other central nervous system tumors in the Surveillance, Epidemiology, and End Results Program , 2020, Neuro-oncology advances.

[6]  G. Schreier,et al.  Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience. , 2020, European journal of cancer.

[7]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. , 2020, Neuro-oncology.

[8]  Timothy R. Smith,et al.  Socioeconomic Disparities Associated With MGMT Promoter Methylation Testing for Patients With Glioblastoma. , 2020, JAMA oncology.

[9]  K. Ligon,et al.  WNT-Activated Medulloblastomas With Hybrid Molecular Subtypes. , 2020, JCO precision oncology.

[10]  Marilyn M. Li,et al.  Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas. , 2020, Cancer cell.

[11]  C. Hawkins,et al.  Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study , 2019, Acta Neuropathologica.

[12]  J. Barnholtz-Sloan,et al.  The Misclassification of Diffuse Gliomas: Rates and Outcomes , 2019, Clinical Cancer Research.

[13]  K. Jung,et al.  A Nationwide, Population-Based Epidemiologic Study of Childhood Brain Tumors in Korea, 2005–2014: A Comparison with United States Data , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[14]  Jill S Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. , 2018, Neuro-oncology.

[15]  E. Neromyliotis,et al.  Paediatric gliomas: diagnosis, molecular biology and management. , 2018, Annals of translational medicine.

[16]  Till Acker,et al.  DNA methylation-based classification of central nervous system tumours , 2018, Nature.

[17]  M. Kool,et al.  Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation , 2018, Acta Neuropathologica.

[18]  D. Boffa,et al.  Using the National Cancer Database for Outcomes Research: A Review , 2017, JAMA oncology.

[19]  Sirintra Nakjang,et al.  Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study , 2017, The Lancet. Oncology.

[20]  Roland Eils,et al.  The whole-genome landscape of medulloblastoma subtypes , 2017, Nature.

[21]  S. Curtin,et al.  Declines in Cancer Death Rates Among Children and Adolescents in the United States, 1999-2014. , 2016, NCHS data brief.

[22]  D. Brat,et al.  Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004–2012, varying) , 2016, Journal of Neuro-Oncology.

[23]  Mei Lu,et al.  Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. , 2016, Cancer cell.

[24]  Peng-Fei Li,et al.  Brain metastasis in children with stage 4 neuroblastoma after multidisciplinary treatment , 2015, Chinese journal of cancer.

[25]  F. Berthold,et al.  Incidence, Trends, and Survival of Children With Embryonal Tumors , 2015, Pediatrics.

[26]  D. Brat,et al.  Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004–2011 , 2015, Journal of Neuro-Oncology.

[27]  Jill S Barnholtz-Sloan,et al.  Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. , 2015, Neuro-oncology.

[28]  Andrew Ma,et al.  Comparison of Cases Captured in the National Cancer Data Base with Those in Population-based Central Cancer Registries , 2013, Annals of Surgical Oncology.

[29]  Susan M. Chang,et al.  Pediatric brain tumors: Current treatment strategies and future therapeutic approaches , 2009, Neurotherapeutics.

[30]  Richard G Grundy,et al.  Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Kristin L. Sainani,et al.  Incidence Patterns of Central Nervous System Germ Cell Tumors: A SEER Study , 2009, Journal of pediatric hematology/oncology.

[32]  Dabiao Zhou,et al.  Epidemiology of Nervous System Tumors in Children: A Survey of 1,485 Cases in Beijing Tiantan Hospital from 2001 to 2005 , 2008, Pediatric Neurosurgery.

[33]  Kai-Ping Chang,et al.  Primary pediatric brain tumors , 2005, Cancer.

[34]  Eva Steliarova-Foucher,et al.  International Classification of Childhood Cancer, third edition , 2005, Cancer.

[35]  K. Mori,et al.  Brain tumors in childhood: Statistical analysis of cases from the brain tumor registry of Japan , 1986, Child's Nervous System.

[36]  J. Chi,et al.  Pediatric brain tumors: statistics of SNUH, Korea (1959–2000) , 2002, Child's Nervous System.

[37]  G. Heller,et al.  Neuroblastoma metastatic to the central nervous system , 2001, Cancer.

[38]  E. Kramárová,et al.  The international classification of childhood cancer , 1996, International journal of cancer.